Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02073357
Other study ID # 13-1195
Secondary ID
Status Withdrawn
Phase N/A
First received February 25, 2014
Last updated July 29, 2014
Start date July 2014

Study information

Verified date July 2014
Source The Cleveland Clinic
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review BoardAustralia: Human Research Ethics CommitteeAustralia: National Health and Medical Research Council
Study type Interventional

Clinical Trial Summary

General anaesthesia is a reversible drug-induced coma. Too little can result in patients being partially conscious during surgery; too much can slow recovery after surgery. There is a range of drug doses that can be used and some anesthesiologists use more than others. There is no convincing evidence that any particular dose within the usual range is better. Consequently, there are no guidelines on the best depth of anaesthesia. This study will determine whether general anesthetic concentrations at the low end of the usual range are better than those at the high end.

Participants will randomly be assigned to lighter or deeper general anesthesia. The first day after surgery, two short questionnaires about recovery and memories of the surgery will be completed. During the rest of the participant's hospital stay, a survey about how one feels will be completed.

There will be two telephone contacts after discharge from the hospital. One month after surgery three questionnaires will be completed about performing daily tasks, how you feel and memories of the surgery. Then one year after surgery pain will be assessed.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date
Est. primary completion date January 2019
Accepts healthy volunteers No
Gender Both
Age group 60 Years and older
Eligibility Inclusion Criteria:

- Age =60 years

- ASA physical status 3 or 4

- surgery expected to last =2 hours

- post-operative hospital stay expected to be =2 nights

- general anaesthesia with or without major regional block

- able to monitor BIS throughout anaesthesia

Exclusion Criteria:

- Unable to monitor BIS (e.g. cranial or intracranial surgery)

- unable to consent

- surgery with 'wake-up' test

- propofol infusion for part or all of maintenance of anaesthesia ('total intravenous anaesthesia')

- previous enrolment in Balanced study

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Effect of General Anesthetic Dose on Recovery From Surgery

Intervention

Procedure:
Light general anaesthesia (BIS = 50)

deep general anaesthesia (BIS = 35)


Locations

Country Name City State
United States Cleveland Clinic Cleveland Ohio

Sponsors (2)

Lead Sponsor Collaborator
The Cleveland Clinic National Health and Medical Research Council, Australia

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary One-year all-cause mortality One year Yes